GLOO:NASDAQGloo Holdings, Inc. Analysis
Data as of 2026-07-23 - not real-time
$3.28
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Gloo Holdings trades at $3.28, well below its 52‑week high of $9.98 and just above the calculated support of $2.94. The RSI of 34 signals that the stock is in oversold territory, while the MACD histogram turned positive, giving a bullish signal. Volume is on an increasing trend, supporting the technical rebound. Valuation metrics show a forward P/E of 10.9 versus an industry average of 33.7, indicating a substantial discount. The price‑to‑book of 2.17 and upside/downside potential of +276% further underline the cheapness. However, fundamentals are weak: operating margin is –45%, net loss per share of –$1.83 and negative operating cash flow.
The recent underwritten public offering raised $22.75 million, adding liquidity and extending the runway. Debt‑to‑equity sits at 29%, modest for a company of this size, and beta of 0.54 suggests lower market volatility relative to the S&P 500. Yet 30‑day volatility is extremely high at roughly 99%, reflecting price swings. The “Extreme Greed” reading on the Fear & Greed Index indicates strong market appetite for risk‑on stocks. With a market cap of $287 million and a niche AI‑driven platform for faith‑based organizations, the growth narrative hinges on scaling subscriptions. In sum, the stock presents a high‑reward, high‑risk profile that may appeal to investors comfortable with volatility.
The recent underwritten public offering raised $22.75 million, adding liquidity and extending the runway. Debt‑to‑equity sits at 29%, modest for a company of this size, and beta of 0.54 suggests lower market volatility relative to the S&P 500. Yet 30‑day volatility is extremely high at roughly 99%, reflecting price swings. The “Extreme Greed” reading on the Fear & Greed Index indicates strong market appetite for risk‑on stocks. With a market cap of $287 million and a niche AI‑driven platform for faith‑based organizations, the growth narrative hinges on scaling subscriptions. In sum, the stock presents a high‑reward, high‑risk profile that may appeal to investors comfortable with volatility.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Oversold RSI and bullish MACD signal a near‑term bounce
- Recent capital raise improves cash runway
- Technical support level near current price
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Continued revenue growth potential but negative margins
- High price volatility may cause wide swing range
- Valuation still attractive relative to industry peers
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued forward P/E versus industry average
- Large upside potential indicated by upside/downside metric
- Niche AI platform with scalable subscription model
Key Metrics & Analysis
Financial Health
Revenue Growth237.60%
Profit Margin-119.10%
P/E Ratio10.9
ROE-188.07%
Debt/Equity29.04
P/B Ratio2.2
Op. Cash Flow$-76435000
Industry P/E33.7
Technical Analysis
TrendBearish
RSI34.2
Support$2.94
Resistance$4.97
MA 20$3.77
MA 50$4.67
MA 200$5.86
MACDBullish
VolumeIncreasing
Fear & Greed Index87.73
Valuation
Target Price$12.33
Upside/Downside276.02%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.54
Volatility98.72%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.